GALGT2 gene therapy for Duchenne Muscular Dystrophy – A translational research journey
Lundi 18 juin 2018 – 12h-13h
Paul T. Martin, Ph.D. (Professor of Pediatrics, Professor of Physiology and Cell Biology, The Ohio State University College of Medicine, Principal Investigator, Center for Gene Therapy, The Research Institute at Nationwide Children’s Hospital, Associate Director, NIH Center of Research Translation in Muscular Dystrophy Therapeutic Development)
Host : Valérie Allamand
Auditorium de l’Institut de Myologie, bâtiment Babinski
Hôpital de la Pitié-Salpêtrière
entrée 82 bd Vincent Auriol
métro Chevaleret
